Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. - Butt JH; Jhund PS; Henderson AD; Claggett BL; Desai AS; Lam CSP; Mueller K; Scheerer MF; Viswanathan P; Senni M; Shah SJ; Voors AA; et al. (European journal of heart failure, 2025)